NCT00287833View on ClinicalTrials.gov

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
OTHER

placebo

Given orally

DRUG

Bowman-Birk inhibitor concentrate

Given orally

Trial Locations (1)

19104

Abramson Cancer Center of The University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00287833 - Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men | Biotech Hunter | Biotech Hunter